The page is the record's research on the issuer — no analyst, no rating, no view. # SHIELD THERAPEUTICS PLC (AIM: STX) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing SHIELD THERAPEUTICS PLC is listed on AIM under ticker STX, with ISIN GB00BYV81293 and LEI 213800G74QWY15FC3W71. Its security type is Corporate and its segment is ASQ1. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted. ## The disclosure read The record holds 47 filings in the twelve months to 2026-11-06, across 40 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-03, 3 days before the record date, and is of type financial_statement. The AIM exchange median is 7.0 days of cadence gap across 594 issuers, with a median of 33.5 filings and a median latency of 4 days. The sector median on this market is 6.0 days of cadence gap across 51 issuers, with a median of 42 filings and a median latency of 4.0 days. ## Auditor The auditor of record is Crowe U.K. LLP. The auditor's location is not on the record. Auditor changes are not on the record, as the market's record does not yet carry a lifecycle type map. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the market's record does not yet carry a lifecycle type map. The halt flag is listed, not halted. ## Orderability For the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed as served. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/STX (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/09761509 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/STX/shield-therapeutics-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/STX (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUyMzIyOTc4N2FkaXF6a2N4/document?format=pdf&download=0 (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.uk-cm-kg.ai/record/AIM/STX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/STX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp